miR-106b-25 Dysregulation in Complex Regional Pain Syndrome Contributes to T Cell Dysfunction
- Categories
- Abstracts
- Topics:
- Exosomes
- Extracellular Vesicles
- miRNA WTA
Categories
Filter by Topics
ADCC Gene Alteration adolescents ALK Angiogenesis Apoptosis Autocrine Signaling Biology of neoplasia Biomarkers Bladder Cancer Blood Brain Breast Cancer Cardiovascular Disease CDKN2A mutation Cell Free Plasma Cells Chemokines Circulating miRNAs Colorectal cancer Comparison study Core Needle Biopsy COVID-19 Custom mRNA Cytokines Developmental Immunotherapy Developmental Therapeutics Diabetes Differential Expression Differential Gene Expression Analysis DLBCL Drug Response Efficacy EMT Epstein-Barr ERBB3 Esophageal Cancer Exosomes extracellular miRNAs Extracellular Vesicles Feasibility FFPE FGF Ligand Trap FGFR Follicular lymphoma Gene Expression Gene Expression Profiling Gene Fusions Gene Signature Analysis Genetic Polymorphism Genitourinary cancer Glioblastoma Tumors Head and Neck Cancer Heart HER-2 HER2- HLA-E Homing HPV HR+ HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq DLBCL Cell of Origin Assay EU HTG EdgeSeq EGFR KRAS and BRAF Mutation Assay HTG EdgeSeq Immune Response Panel HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq Immuno-Oncology Panel HTG EdgeSeq Lung Fusion Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq miRNA Whole Transcriptome Panel HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq PATH Assay HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq System Immune Cells Immune Checkpoint Inhibitors Immune Response Immune System Immuno-Oncology Immunotherapy Integrins Kidney Liposarcoma Liquid Biopsy Liver liver tissue Lung Lupus Lymphocytes Lymphoma Melanoma Mesothelioma Microenvironment miRNA miRNA WTA Molecular Characterization Mouse mRNA custom mTOR signaling Multiple Myeloma MYC Natural Killer Cells Neoantigens Novel Therapeutic Targets Oral Cancer Osteoarthritis PALLET PALOMA-2 Pancreas Pathway Analysis Patient Stratification PAXgene PBMCs PCA Cell Lines PD-L1 PENELOPE-B PFAS PIK3CA mutation Plasma Platform Comparison Programmed cell death protein 1 Prostate Prostate Cancer qNPA qPCR Renal Cell Carcinoma Reproductive Reveal Rheumatoid Arthritis safety Sarcoma Serum Signaling Inhibitors Signaling Pathways Signature Validation Signatures Sinonasal Carcinoma Squamous cell carcinoma Sub-typing Therapeutic Response TMB Toxicity TP53 mutation Transplantation Treatment Outcome Treatment Stratification Tumor Biology Tumor Immunobiology Tumor infiltrating lymphocytes tumor microenvironment Tumor Microenvironment Urine Urothelial carcinoma VEGFR Xenograft Tissue2022
Abstract PD2-07: Impact of using cross-platform gene expression profiling technologies and computational methods for intrinsic breast cancer subtyping in PALOMA-2 and PALLET
Cheang, M. et al., Abstract PD2-07: Impact of using cross-platform gene expression profiling technologies and computational methods for intrinsic breast cancer subtyping in PALOMA-2 and PALLET
- Categories
- Abstracts
- Topics:
- Breast Cancer
- HER-2
- PALLET
- PALOMA-2
Abstract PD2-04: Molecular plasticity of luminal breast cancer and response to CDK 4/6 inhibition - The biomarker program of the PENELOPE-B trial investigating post-neoadjuvant palbociclib
Denkert, C., et al., Abstract PD2-04: Molecular plasticity of luminal breast cancer and response to CDK 4/6 inhibition - The biomarker program of the PENELOPE-B trial investigating post-neoadjuvant palbociclib
- Categories
- Abstracts
- Topics:
- Breast Cancer
- HER2-
- HR+
- PENELOPE-B
Cell-free plasma microRNAs that identify patients with glioblastoma
Bustos M., et al., Cell-free plasma microRNAs that identify patients with glioblastoma
- Categories
- Abstracts
2021
Associations between liver PFAS concentrations and plasma extracellular miRNAs in a cohort of adolescents undergoing bariatric surgery
Stratakis, N., et al., Associations between liver PFAS concentrations and plasma extracellular miRNAs in a cohort of adolescents undergoing bariatric surgery, Environemental Health Perspectives, https://ehp.niehs.nih.gov/doi/abs/10.1289/isee.2021.O-TO-140
Associations of immune cell homing gene signatures and infiltrates of lymphocyte subsets in human melanomas: discordance with CD163+ myeloid cell infiltrates
Kwak, M., et al., Associations of immune cell homing gene signatures and infiltrates of lymphocyte subsets in human melanomas: discordance with CD163+ myeloid cell infiltrates, J Transl Med 19, 371 (2021). https://doi.org/10.1186/s12967-021-03044-5
The Relationship of Genetics and Clinically suspect Arthralgia in RA Development assessed using HC, CSA and RA Patients
Maurits, M., et al. The Relationship of Genetics and Clinically suspect Arthralgia in RA Development assessed using HC, CSA and RA Patients. Annals of Rheumatic Diseases 2021(80):1
- Categories
- Abstracts
Evaluation of the Effect of mTOR Expression on the Clinical Manifestations of Knee Osteoarthritis in Obese and Normal Weight Patients
Strebkova, E., et al. Evaluation of the Effect of mTOR Expression on the Clinical Manifestations of Knee Osteoarthritis in Obese and Normal Weight Patients. Annals of Rheumatic Diseases 2021(80):1
- Categories
- Abstracts
Antigen-experienced CXCR5- CD19low B cells are plasmablast precursors expanded in SLE
Dorner, T., et al. Antigen-experienced CXCR5- CD19low B cells are plasmablast precursors expanded in SLE. medRxiv preprint May 27, 2021 https://doi.org/10.1101/2021.05.25.21257784doi
- Categories
- Abstracts
Diagnostic ability of four cell-free miRNA signatures pre- and post-nephrectomy concordantly found in the tumor and blood from patients with renal cell carcinoma.
Bustos, M. A., et al. Diagnostic ability of four cell-free miRNA signatures pre- and post-nephrectomy concordantly found in the tumor and blood from patients with renal cell carcinoma. J Clin Oncol 39, 2021 (suppl 15; abstr e16577); DOI: 10.1200/JCO.2021.39.15_suppl.e16577
- Categories
- Abstracts
Subgroup of post-neoadjuvant luminal-B tumors assessed by HTG in PENELOPE-B investigating palbociclib in high risk HER2-/HR+ breast cancer with residual disease.
Denkert, C., et al. Subgroup of post-neoadjuvant luminal-B tumors assessed by HTG in PENELOPE-B investigating palbociclib in high risk HER2-/HR+ breast cancer with residual disease. J Clin Oncol 39, 2021 (suppl 15; abstr 519) DOI: 10.1200/JCO.2021.39.15_suppl.519
Durvalumab improves long-term outcome in TNBC: results from the phase II randomized GeparNUEVO study investigating neodjuvant durvalumab in addition to an anthracycline/taxane based neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC).
Loibl, S., et al. Durvalumab improves long-term outcome in TNBC: results from the phase II randomized GeparNUEVO study investigating neodjuvant durvalumab in addition to an anthracycline/taxane based neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC). J Clin Oncol 39, 2021 (suppl 15; abstr 506) DOI: 10.1200/JCO.2021.39.15_suppl.506
- Categories
- Abstracts
Page last updated July 19, 2022